Canna~Fangled Abstracts A RANDOMIZED, CONTROLLED TRIAL OF EFFICACY AND SAFETY OF CANNABIDIOL IN IDIOPATHIC AND DIABETIC GASTROPARESIS Clin Gastroenterol Hepatol. 2023 Jul 21;S1542-3565(23)00543-8. doi: 10.1016/j.cgh.2023.07.008. Online ahead of print. Ting Zheng 1, Joelle BouSaba 1, Ann…Freedom WaresJuly 21, 2023
Canna~Fangled Abstracts CANNABIDIOL FOR FUNCTIONAL DYSPEPSIA WITH NORMAL GASTRIC EMPTYING: A RANDOMIZED, CONTROLLED TRIAL Am J Gastroenterol. 2022 May 9. doi: 10.14309/ajg.0000000000001805. Online ahead of print. Jessica Atieh 1, Daniel Maselli 1, Margaret…Freedom WaresMay 9, 2022
Canna~Fangled Abstracts Pharmacological inhibition of cannabinoid receptor 1 stimulates gastric release of nesfatin-1 via the mTOR pathway. World J Gastroenterol. 2017 Sep 21;23(35):6403-6411. doi: 10.3748/wjg.v23.i35.6403. Folgueira C1, Barja-Fernandez S1, Prado L1, Al-Massadi…Freedom WaresSeptember 21, 2017